148 studies found for:    Sjogren's Syndrome
Show Display Options
Rank Status Study
21 Terminated
Has Results
Pilot Study of Raptiva to Treat Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Raptiva
22 Withdrawn Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Conditions: Primary Sjogren's Syndrome;   Secondary Sjogren's Syndrome;   Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention: Drug: Abatacept
23 Recruiting Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
Conditions: Sjögren Syndrome;   Pulmonary Hypertension
Intervention:
24 Not yet recruiting Acupuncture for Primary Sjögren Syndrome
Condition: Sjogren's Syndrome
Interventions: Device: acupuncture group;   Device: Sham Acupuncture group
25 Recruiting Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Procedure: Sialoendoscopy;   Drug: saline;   Drug: hydrocortisone
26 Not yet recruiting the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
27 Enrolling by invitation Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
28 Completed A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
Conditions: Dry Eye Syndromes;   Sjögren Syndrome
Intervention:
29 Active, not recruiting Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
Condition: Sjogren's Syndrome
Intervention: Drug: dehydroepiandrosterone
30 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
31 Terminated
Has Results
Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
32 Recruiting Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Abatacept SC
33 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
34 Enrolling by invitation Salivary Biomarkers for Sjögren's Syndrome Detection
Condition: Sjögren's Syndrome
Intervention:
35 Completed The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
Condition: Sjogren's Syndrome
Intervention:
36 Completed Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
Condition: Sjögren's Syndrome Patients With Severe Dry Eye
Interventions: Drug: 0.02% Fm, SH;   Drug: 0.02% Fm, SH, 0.05% CsA;   Other: 0.02% Fm, SH, tBCL;   Drug: 0.02% Fm, SH, AS
37 Withdrawn Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736 lower dose;   Drug: VAY736 higher dose
38 Recruiting A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Condition: Sjögren's Syndrome
Interventions: Drug: LY3090106;   Drug: Placebo
39 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab
40 Recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.